These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23153688)

  • 41. Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
    Vasan RS; Evans JC; Larson MG; Wilson PW; Meigs JB; Rifai N; Benjamin EJ; Levy D
    N Engl J Med; 2004 Jul; 351(1):33-41. PubMed ID: 15229305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Primary hyperaldosteronism in a population of hypertensive patients].
    Lorenzo Villalba N; Rivera Martínez E; Artiles Vizcaíno J; Sablón González N; Marrero Medina I; Suárez Ortega S
    Medicina (B Aires); 2019; 79(3):185-190. PubMed ID: 31284252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of Primary Hyperaldosteronism in Young Hypertensives in a Tertiary Care Setting of Rawalpindi.
    Gilani M; Asif N; Nawaz A; Akram A
    J Coll Physicians Surg Pak; 2019 Jan; 29(1):58-61. PubMed ID: 30630571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiac consequences of primary hyperaldosteronism].
    du Cailar G
    Ann Cardiol Angeiol (Paris); 2004 Jun; 53(3):147-9. PubMed ID: 15291171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.
    Maron BA; Opotowsky AR; Landzberg MJ; Loscalzo J; Waxman AB; Leopold JA
    Eur J Heart Fail; 2013 Mar; 15(3):277-83. PubMed ID: 23111998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal damage in primary aldosteronism: results of the PAPY Study.
    Rossi GP; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mannelli M; Matterello MJ; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Pessina AC; Mantero F;
    Hypertension; 2006 Aug; 48(2):232-8. PubMed ID: 16801482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
    Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Itoh H; Umakoshi H; Tsuiki M; Ichijo T; Katabami T; Tanaka Y; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Okamura S; Miyauchi S; Fukuoka T; Izawa S; Yoneda T; Hashimoto S; Yanase T; Suzuki T; Kawamura T; Tabara Y; Matsuda F; Naruse M; ;
    Hypertension; 2018 Mar; 71(3):530-537. PubMed ID: 29358460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary hyperaldosteronism associated with hypertensive emergencies.
    Labinson PT; White WB; Tendler BE; Mansoor GA
    Am J Hypertens; 2006 Jun; 19(6):623-7. PubMed ID: 16783876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia.
    Williams JS; Williams GH; Raji A; Jeunemaitre X; Brown NJ; Hopkins PN; Conlin PR
    J Hum Hypertens; 2006 Feb; 20(2):129-36. PubMed ID: 16292348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary aldosteronism and its various clinical scenarios.
    Martell-Claros N; Abad-Cardiel M; Alvarez-Alvarez B; García-Donaire JA; Pérez CF
    J Hypertens; 2015 Jun; 33(6):1226-32. PubMed ID: 25715092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.
    Shigematsu Y; Hamada M; Okayama H; Hara Y; Hayashi Y; Kodama K; Kohara K; Hiwada K
    Hypertension; 1997 Mar; 29(3):723-7. PubMed ID: 9052887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
    Monticone S; D'Ascenzo F; Moretti C; Williams TA; Veglio F; Gaita F; Mulatero P
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):41-50. PubMed ID: 29129575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.
    Born-Frontsberg E; Reincke M; Rump LC; Hahner S; Diederich S; Lorenz R; Allolio B; Seufert J; Schirpenbach C; Beuschlein F; Bidlingmaier M; Endres S; Quinkler M;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1125-30. PubMed ID: 19190103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Murdoch D; Kennedy JA; Connell JM
    J Hypertens; 1995 May; 13(5):551-6. PubMed ID: 7561013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary aldosteronism in the primary care setting.
    Buffolo F; Monticone S; Tetti M; Mulatero P
    Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):155-159. PubMed ID: 29629943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is familial hyperaldosteronism underdiagnosed in hypertensive children?
    Mulatero P; Williams TA; Monticone S; Veglio F
    Hypertension; 2011 Jun; 57(6):1053-5. PubMed ID: 21502569
    [No Abstract]   [Full Text] [Related]  

  • 57. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence.
    Börgel J; Springer S; Ghafoor J; Arndt D; Duchna HW; Barthel A; Werner S; Van Helden J; Hanefeld C; Neubauer H; Bulut D; Mügge A
    Clin Res Cardiol; 2010 Aug; 99(8):499-506. PubMed ID: 20361196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of global risk assessment on the evaluation of hypertensive patients treated by primary care physicians in Korea (a Nation-Wide, Multi-Center, Observational, Cross-Sectional, Epidemiologic Study to Evaluate the Proportion of Cardiovascular Risk Factors in Korean hypertensive patients: WONDER study).
    Kim KI; Lee YS; Park CG
    Hypertens Res; 2014 Jul; 37(7):665-71. PubMed ID: 24739540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?
    Baguet JP; Steichen O; Mounier-Véhier C; Gosse P
    Ann Endocrinol (Paris); 2016 Jul; 77(3):187-91. PubMed ID: 27087531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevalence of masked hypertension in a cohort of controlled hypertensive patients in Spain].
    Sobrino J; Domenech M; Camafort M; Vinyoles E; Coca A;
    Med Clin (Barc); 2011 May; 136(14):607-12. PubMed ID: 21440916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.